GreenLight Biosciences Holdings PBC (GRNA) Stock Analyst Ratings
NASDAQ:GRNA - Nasdaq - US39536G1058 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 46% to GRNA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.46. This target is 53.26% above the current price.
GRNA was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about GRNA.
In the previous month the buy percentage consensus was at a similar level.
GRNA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-05-31 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2022-12-08 | Canaccord Genuity | Initiate | Buy |
| 2022-10-14 | Credit Suisse | Initiate | Outperform |